SU900812A3 - Способ получени гидрохлорида 6,7-диметокси-4-амино-2-[4-(2-фуроил)-1-пиперазинил-ХИНАЗОЛИНА - Google Patents

Способ получени гидрохлорида 6,7-диметокси-4-амино-2-[4-(2-фуроил)-1-пиперазинил-ХИНАЗОЛИНА Download PDF

Info

Publication number
SU900812A3
SU900812A3 SU802874898A SU2874898A SU900812A3 SU 900812 A3 SU900812 A3 SU 900812A3 SU 802874898 A SU802874898 A SU 802874898A SU 2874898 A SU2874898 A SU 2874898A SU 900812 A3 SU900812 A3 SU 900812A3
Authority
SU
USSR - Soviet Union
Prior art keywords
dimethoxy
furoyl
piperazinyl
amino
producing
Prior art date
Application number
SU802874898A
Other languages
English (en)
Russian (ru)
Inventor
Юхани Хонканен Эркки
Кюлликки Пиппури Айно
Юхани Каирисало Пекка
Талер Хейнрик
Катрина Коивисто Майя
Аннели Туоми Сирпа
Original Assignee
Орион-Ихтюмя Ой (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Орион-Ихтюмя Ой (Фирма) filed Critical Орион-Ихтюмя Ой (Фирма)
Application granted granted Critical
Publication of SU900812A3 publication Critical patent/SU900812A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
SU802874898A 1979-01-31 1980-01-30 Способ получени гидрохлорида 6,7-диметокси-4-амино-2-[4-(2-фуроил)-1-пиперазинил-ХИНАЗОЛИНА SU900812A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI790320A FI67699C (fi) 1979-01-31 1979-01-31 Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan

Publications (1)

Publication Number Publication Date
SU900812A3 true SU900812A3 (ru) 1982-01-23

Family

ID=8512343

Family Applications (1)

Application Number Title Priority Date Filing Date
SU802874898A SU900812A3 (ru) 1979-01-31 1980-01-30 Способ получени гидрохлорида 6,7-диметокси-4-амино-2-[4-(2-фуроил)-1-пиперазинил-ХИНАЗОЛИНА

Country Status (21)

Country Link
US (1) US4271300A (US06168655-20010102-C00055.png)
JP (1) JPS55104280A (US06168655-20010102-C00055.png)
AT (1) AT374475B (US06168655-20010102-C00055.png)
BE (1) BE881297A (US06168655-20010102-C00055.png)
CA (1) CA1128945A (US06168655-20010102-C00055.png)
CH (1) CH644605A5 (US06168655-20010102-C00055.png)
CS (1) CS214692B2 (US06168655-20010102-C00055.png)
DD (1) DD148952A1 (US06168655-20010102-C00055.png)
DE (1) DE3002553A1 (US06168655-20010102-C00055.png)
DK (1) DK158352C (US06168655-20010102-C00055.png)
FI (1) FI67699C (US06168655-20010102-C00055.png)
FR (1) FR2447920A1 (US06168655-20010102-C00055.png)
GB (1) GB2041932B (US06168655-20010102-C00055.png)
HU (1) HU181016B (US06168655-20010102-C00055.png)
NL (1) NL190701C (US06168655-20010102-C00055.png)
NO (1) NO152298C (US06168655-20010102-C00055.png)
PL (1) PL126994B1 (US06168655-20010102-C00055.png)
SE (1) SE430692B (US06168655-20010102-C00055.png)
SU (1) SU900812A3 (US06168655-20010102-C00055.png)
YU (1) YU41498B (US06168655-20010102-C00055.png)
ZA (1) ZA80501B (US06168655-20010102-C00055.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1390014A (en) * 1971-05-07 1975-04-09 Koninklijke Pharma Fab Nv Process for the preparation of carbocyclic fused pyrimidine derivatives
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI58124C (fi) * 1976-12-15 1980-12-10 Orion Yhtymae Oy Ny mellanprodukt 3,4-dimetoxi-6-(4-(2-furoyl)-1-piperazinyltiokarbamido)-bensonitril foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan
FI58125C (fi) * 1976-12-15 1985-01-02 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande vekan

Also Published As

Publication number Publication date
HU181016B (en) 1983-05-30
NL190701B (nl) 1994-02-01
GB2041932A (en) 1980-09-17
FI67699C (fi) 1985-05-10
JPS6310955B2 (US06168655-20010102-C00055.png) 1988-03-10
DD148952A1 (de) 1981-06-17
FI67699B (fi) 1985-01-31
ATA19580A (de) 1983-09-15
NO152298B (no) 1985-05-28
CH644605A5 (de) 1984-08-15
BE881297A (fr) 1980-05-16
DK42680A (da) 1980-08-01
AT374475B (de) 1984-04-25
US4271300A (en) 1981-06-02
DK158352B (da) 1990-05-07
YU5880A (en) 1983-02-28
PL221684A1 (US06168655-20010102-C00055.png) 1980-10-20
JPS55104280A (en) 1980-08-09
FR2447920B1 (US06168655-20010102-C00055.png) 1982-12-03
CS214692B2 (en) 1982-05-28
PL126994B1 (en) 1983-09-30
FI790320A (fi) 1980-08-01
DE3002553A1 (de) 1980-08-07
YU41498B (en) 1987-08-31
NO794279L (no) 1980-08-01
CA1128945A (en) 1982-08-03
GB2041932B (en) 1982-10-27
DE3002553C2 (US06168655-20010102-C00055.png) 1988-10-27
ZA80501B (en) 1981-02-25
NL8000289A (nl) 1980-08-04
DK158352C (da) 1990-10-08
NL190701C (nl) 1994-07-01
FR2447920A1 (fr) 1980-08-29
NO152298C (no) 1985-09-04
SE430692B (sv) 1983-12-05
SE8000777L (sv) 1980-08-01

Similar Documents

Publication Publication Date Title
TR200003632T2 (tr) Benzotiyepin-1,1-dioksid türevleri, üretim yöntemi, bunları içeren ilaçlar.
SU900812A3 (ru) Способ получени гидрохлорида 6,7-диметокси-4-амино-2-[4-(2-фуроил)-1-пиперазинил-ХИНАЗОЛИНА
TR200103352T2 (tr) Kinas pirolotriazin inhibitörleri
ATE26112T1 (de) Isochinolin-sulfonamidderivate und verfahren fuer ihre herstellung.
ATE144774T1 (de) Verfahren zur herstellung von pyrrolo (2,3- d)pyrimidinen
TR199800608A2 (en) Propanolamin t�revleri, bunlar�n �retim usul�.
ATE19776T1 (de) Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE15187T1 (de) Substituierte cyclische amine.
RU93046065A (ru) Способ получения производных физостигминкарбамата
RU2004116345A (ru) Способы получения замещенных бициклических производных, полезных для лечения патологического роста клеток
BR8205587A (pt) Derivados de acidos 4-fenoxialcanocarboxilicos heterociclicamente substituidos,processos para sua obtencao,agentes herbicidas e reguladores de crescimento,aplicacao dos ditos compostos,bem como processos para combate de crescimento indesejado de plantas e para regulagem do crescimento de plantas uteis
EP0146642B1 (de) Verfahren zur Herstellung von 4-Amino-6,7-dimethoxy-2-(4-(furo-2-yl)-piperazin-1-yl)-chinazolin und dessen physiologisch annehmbarer Salze
CA2211646A1 (en) Substituted phenyl compounds as endothelin antagonists
GB1441357A (en) Benzophenone derivatives and their production
HU180041B (en) Process for producing 2-bracket-4-furoyl-piperazinyl-bracket closed-4-amino-6,7-dimethoxy-quinasoline derivatives of blood pressure reducing activity
Kitagawa et al. Equilibrium Studies of 5-Substituted 4-Hydroxy-2-methylpyrimidines. I. The Ionization Constants in Aqueous Solution
ES8604488A1 (es) Un procedimiento para la preparacion de un derivado de ace- tileno
EA200200733A1 (ru) Новые гетероарильные производные, их получение и применение
EP0172509A3 (de) Verfahren zur Herstellung optisch aktiver, substituierter 1,4-Dihydropyridine und ihre Verwendung als Arzneimittel
SU724503A1 (ru) Ариламиды о-нитробензолсульфокислоты, про вл ющие диуретическую активность
SU650593A1 (ru) Стимул тор роста растений
TR200101780T2 (tr) Yeni ß-amido ve ß-sülfonamido karboksilik asit türevleri.
SU1214667A1 (ru) @ -Замещенные 3/5/- метилпиразолы как ингибиторы нитрификации азотных удобрений
RO87255B (ro) Procedeu de preparare a unor amide ale acizilor fenoxifenoxialcanoicicu proprietati erbicide
TR200001365T2 (tr) Yeni heterosiklik ikame edilmiş a-hidroksikarbonik asit türevleri